Golden
The Alpha-1 Project

The Alpha-1 Project

The Alpha-1 Project is a for-profit subsidiary of the Alpha-1 Foundation focused on providing a commercial therapy or cure for Alpha-1 antitrypsin deficiency.

The Alpha-1 Project is a wholly-owned for-profit subsidiary of the Alpha-1 Foundation. They are focused on providing funding for the commercialization of therapies for the elimination of Chronic Obstructive Pulmonary Disease and liver disease caused by Alpha-1 Antitrypsin Deficiency.



The Alpha-1 Project is initially focused on the search for small molecules and chaperones to correct the defect in cellular alpha-1 antitrypsin trafficking and polymerization, development of new molecules with anti-elastase activity and gene or stem cell therapies. They offer access to the Alpha-1 Research Registry database and The Alpha-1 Foundation DNA and Tissue Bank to companies they work with.



The Alpha-1 Project has invested in Apic Bio, during Apic Bio's August 2017 Seed Round.

Timeline

Funded Companies

1 Result
Company
Company
Website
Website
Industry
Industry
Location
Location

People

Name
Role
LinkedIn

Jean-Marc D. Quach

President and CEO



Karen L. Erickson

Chief Operating Officer



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References